HH PHARMA CONSULTANCY LTD 14544629 false 2022-12-16 2023-12-31 2023-12-31 The principal activity of the company is Wholesale of pharmaceutical goods Digita Accounts Production Advanced 6.30.9574.0 true 14544629 2022-12-16 2023-12-31 14544629 2023-12-31 14544629 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 14544629 bus:Micro-entities 2022-12-16 2023-12-31 14544629 bus:AuditExemptWithAccountantsReport 2022-12-16 2023-12-31 14544629 bus:FilletedAccounts 2022-12-16 2023-12-31 14544629 bus:SmallCompaniesRegimeForAccounts 2022-12-16 2023-12-31 14544629 bus:RegisteredOffice 2022-12-16 2023-12-31 14544629 bus:Director1 2022-12-16 2023-12-31 14544629 bus:PrivateLimitedCompanyLtd 2022-12-16 2023-12-31 14544629 countries:EnglandWales 2022-12-16 2023-12-31 iso4217:GBP xbrli:pure

Registration number: 14544629

HH PHARMA CONSULTANCY LTD

Unaudited Filleted Financial Statements

for the Period from 16 December 2022 to 31 December 2023

 

HH PHARMA CONSULTANCY LTD

Contents

Company Information

1

Director's Report

2

Balance Sheet

3 to 4

Notes to the Unaudited Financial Statements

3

 

HH PHARMA CONSULTANCY LTD

Company Information

Director

Pauline Caddick

Registered office

17 Mayfield Road
Warrington
WA4 2NP

Accountants

Beans Accountants Ltd
Chartered Accountant
Suite F/22
The White House
Greenalls Avenue
Warrington
Cheshire
WA4 6HL

 

HH PHARMA CONSULTANCY LTD

Director's Report for the Period from 16 December 2022 to 31 December 2023

The director presents her report and the financial statements for the period from 16 December 2022 to 31 December 2023.

This report has been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and in accordance with FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime.

Incorporation

The company was incorporated on 16 December 2022.

Director of the company

The director who held office during the period was as follows:

Pauline Caddick

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the director on 10 April 2024
 

.........................................
Pauline Caddick
Director

 

HH PHARMA CONSULTANCY LTD

(Registration number: 14544629)
Balance Sheet as at 31 December 2023

2023
£

Fixed assets

685

Current assets

66,000

Prepayments and accrued income

10,089

Creditors: Amounts falling due within one year

(22,319)

Net current assets

53,770

 

54,455

Capital and reserves

54,455

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
17 Mayfield Road
Warrington
WA4 2NP

These financial statements were authorised for issue by the director on 10 April 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 1.

For the financial period ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

 

HH PHARMA CONSULTANCY LTD

(Registration number: 14544629)
Balance Sheet as at 31 December 2023 (continued)

Approved and authorised by the director on 10 April 2024
 

.........................................
Pauline Caddick
Director